Skip to content
About Us
About Synexa
Quality
Management
News
Environmental Sustainability
Services
Translational
Biomarkers
Bioanalysis
Technologies
Mass Spectrometry
Immunoassay
Olink Proteomics
Flow Cytometry
ELISpot
Radiopharmaceutical
Genomics
Tissue Imaging
Dose Formulation Analysis
Expertise
Autoimmune
Oncology
Vaccines
Biosimilars
Resources
Synexa Insights
Guides
Webinars
Events
Careers
Opportunities
Why Join Synexa
About Us
About Synexa
Quality
Management
News
Environmental Sustainability
Services
Translational
Biomarkers
Bioanalysis
Technologies
Mass Spectrometry
Immunoassay
Olink Proteomics
Flow Cytometry
ELISpot
Radiopharmaceutical
Genomics
Tissue Imaging
Dose Formulation Analysis
Expertise
Autoimmune
Oncology
Vaccines
Biosimilars
Resources
Synexa Insights
Guides
Webinars
Events
Careers
Opportunities
Why Join Synexa
Contact
Linkedin-in
Youtube
Blogs
Resources
Blogs
Latest Blogs
Search
The Silence of the Genes: Unlocking Antisense Oligonucleotide Therapies for the Renin-Angiotensin-Aldosterone System
October 22, 2025
The field of gene therapy is rapidly evolving, with antisense oligonucleotide therapies emerging as powerful tools for modulating gene expression.…
Read More
A controlled detonation: Targeted antibody drug conjugates (ADCs) for oncology
September 17, 2024
Are antibody-drug conjugates (ADCs), principally comprised of an antibody, a cytotoxic payload and a linker, the next therapeutic modality of…
Read More
The mpox outbreak: Variants, transmission and the boost for vaccine manufacturers
September 5, 2024
Following Covid-19, the world is collectively on high alert for anything that could indicate another pandemic. What do we know…
Read More
The STING in the tail: How our own defense mechanisms to infection may be working against us
August 29, 2024
In this latest blog, we explore this pathway, its burgeoning links to multiple diseases and how biomarker profiling can assist…
Read More
Falling drug approval rates: What should we be doing differently?
August 6, 2024
Over the years, this failure rate of drug approvals has not seen significant improvement, which begs the question - why?…
Read More
Patient Derived Organoids: Shaping the Fight Against Paediatric Brain Cancer
June 7, 2024
We highlight some of the exciting translational tools that have been developed to understand brain cancer and how these are…
Read More
World Multiple Sclerosis Day 2024: Wider access to crucial antibody therapies
May 30, 2024
Read More
← Previous
Page
1
Page
2
Page
3
Page
4
Page
5
…
Page
13
Next →
Search
Quick Links
Services
Contact us
Synexa Insights
Events
About us
Talk to our Biomarker Experts